Blog

FDA approves Israel-developed stem cell ‘factory’ for research – The Times of Israel

FDA approves Israel-developed stem cell ‘factory’ for research
The Times of Israel
An Israeli-invented process to speed up injury repairs got a big boost last week when the FDA approved the use of mass-produced manufactured therapeutic stem cells produced by Pluristem Therapeutics for use in studies on treating injuries. The
Pluristem Therapeutics Inc. (NASDAQ:PSTI) Granted new Patent by Australian WallStreetPR

all 2 news articles

…read more    

2014-03-10 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.